Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02934529
Title Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus Cetuximab (AIO-KRK-0114)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Ludwig-Maximilians - University of Munich
Indications

rectum adenocarcinoma

colorectal cancer

colon adenocarcinoma

Therapies

Cetuximab + Fluorouracil + Irinotecan + Leucovorin

Bevacizumab + Capecitabine + Fluorouracil + Leucovorin

Regorafenib

Age Groups: adult | senior
Covered Countries DEU

Additional content available in CKB BOOST